A lifetime of attention-deficit/hyperactivity disorder: diagnostic challenges, treatment and neurobiological mechanisms

References

• Crichton A. An inquiry into the nature and origin of mental derangement. J. Atten. Disord.12(3), 200–204 (2008).
   PubMedGoogle Scholar
• Strachey L. Elizabeth and Essex. Cox & Wyman Ltd, London, UK (1971).
   Google Scholar
• Barkley RA, Fischer M, Smallish L, Fletcher K. Young adult follow-up of hyperactive children: antisocial activities and drug use. J. Child. Psychol. Psychiatry45(2), 195–211 (2004).
   PubMed Web of Science ®Google Scholar
• Flory K, Molina BS, Pelham WE, Gnagy E, Smith B. Childhood ADHD predicts risky sexual behavior in young adulthood. J. Clin. Child Adolesc. Psychol.35(4), 571–577 (2006).
   PubMed Web of Science ®Google Scholar
• Jerome L, Habinski L, Segal A. Attention-deficit/hyperactivity disorder (ADHD) and driving risk: a review of the literature and a methodological critique. Curr. Psychiatry Rep.8(5), 416–426 (2006).
   PubMedGoogle Scholar
• Manor I, Gutnik I, Ben-Dor DH et al. Possible association between attention deficit hyperactivity disorder and attempted suicide in adolescents: a pilot study. Eur. Psychiatry25(3), 146–150 (2010).
   PubMed Web of Science ®Google Scholar
• Mendelson W, Johnson N, Stewart MA. Hyperactive children as teenagers: a follow-up study. J. Nerv. Ment. Dis.153(4), 273–279 (1971).
   PubMed Web of Science ®Google Scholar
• Menkes MM, Rowe JS, Menkes JH. A twenty-five year follow-up study on the hyperkinetic child with minimal brain dysfunction. Pediatrics39(3), 393–399 (1967).
   PubMed Web of Science ®Google Scholar
• Fayyad J, Graaf R, Kessler R et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br. J. Psychiatry190, 402–409 (2007).
   PubMed Web of Science ®Google Scholar
• Faraone SV, Sergeant J, Gillberg C, Biederman J. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry2(2), 104–113 (2003).
   PubMedGoogle Scholar
• Ford T, Goodman R, Meltzer H. The British child and adolescent mental health survey 1999: the prevalence of DSM-IV disorders. J. Am. Acad. Child Adolesc. Psychiatry42(10), 1203–1211 (2003).
   PubMed Web of Science ®Google Scholar
• Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am. J. Psychiatry164(6), 942–948 (2007).
   PubMed Web of Science ®Google Scholar
• Polanczyk G, Rohde LA. Epidemiology of attention-deficit/hyperactivity disorder across the lifespan. Curr. Opin. Psychiatry20(4), 386–392 (2007).
   PubMed Web of Science ®Google Scholar
• Conners C, Erhardt D, Sparrow E. The Conner’s Adult ADHD rating scale (CAARS). New York: Multihealth Systems, Inc., New York, NY, USA (1998).
   Google Scholar
• Wender PH. Adult Attention Deficit Hyperactivity Disorder. University Press, Oxford, UK (1995).
   Google Scholar
• Chen W, Zhou K, Sham P et al. DSM-IV combined type ADHD shows familial association with sibling trait scores: a sampling strategy for QTL linkage. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(8), 1450–1460 (2008).
   PubMed Web of Science ®Google Scholar
• Shaw P, Gilliam M, Liverpool M et al. Cortical development in typically developing children with symptoms of hyperactivity and impulsivity: support for a dimensional view of attention deficit hyperactivity disorder. Am. J. Psychiatry168(2), 143–151 (2011).
   PubMed Web of Science ®Google Scholar
• Biederman J, Petty CR, Evans M, Small J, Faraone SV. How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD. Psychiatry Res.177(3), 299–304 (2010).
   PubMed Web of Science ®Google Scholar
• Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol. Med.36(2), 159–165 (2006).
   PubMed Web of Science ®Google Scholar
• Kessler RC, Adler L, Barkley R et al. The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication. Am. J. Psychiatry163(4), 716–723 (2006).
   PubMed Web of Science ®Google Scholar
• Monuteaux MC, Mick E, Faraone SV, Biederman J. The influence of sex on the course and psychiatric correlates of ADHD from childhood to adolescence: a longitudinal study. J. Child Psychol. Psychiatry51(3), 233–241 (2010).
   PubMed Web of Science ®Google Scholar
• Biederman J, Mick E, Faraone SV et al. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am. J. Psychiatry159(1), 36–42 (2002).
   PubMed Web of Science ®Google Scholar
• Biederman J, Faraone SV, Mick E et al. Clinical correlates of ADHD in females: Findings from a large group of girls ascertained from pediatric and psychiatric referral sources. J. Am. Acad. Child Adolesc. Psychiatry38(8), 966–975 (1999).
   PubMed Web of Science ®Google Scholar
• Nigg JT, Willcutt EG, Doyle AE, Sonuga-Barke EJS. Causal heterogeneity in attention-deficit/hyperactivity disorder: do we need neuropsychologically impaired subtypes? Biol. Psychiatry57(11), 1224–1230 (2005).
   PubMed Web of Science ®Google Scholar
• Sonuga-Barke EJ. The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics. Neurosci. Biobehav. Rev.27(7), 593–604 (2003).
   PubMed Web of Science ®Google Scholar
• Sonuga-Barke EJS. Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways. Biol. Psychiatry57(11), 1231–1238 (2005).
   PubMed Web of Science ®Google Scholar
• Halmoy A, Fasmer OB, Gillberg C, Haavik J. Occupational outcome in adult ADHD: impact of symptom profile, comorbid psychiatric problems, and treatment: a cross-sectional study of 414 clinically diagnosed adult ADHD patients. J. Atten. Disord.13(2), 175–187 (2009).
   PubMed Web of Science ®Google Scholar
• Jacob C, Romanos J, Dempfle A et al. Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center. Eur. Arch. Psychiatry Clin. Neurosci.257(6), 309–317 (2007).
   PubMed Web of Science ®Google Scholar
• Wilens TE, Biederman J, Faraone SV, Martelon M, Westerberg D, Spencer TJ. Presenting ADHD symptoms, subtypes, and comorbid disorders in clinically referred adults with ADHD. J. Clin. Psychiatry70(11), 1557–1562 (2009).
   PubMed Web of Science ®Google Scholar
• Barkley RA, Fischer M, Smallish L, Fletcher K. Young adult outcome of hyperactive children: adaptive functioning in major life activities. J. Am. Acad. Child Adolesc. Psychiatry45(2), 192–202 (2006).
   PubMed Web of Science ®Google Scholar
• Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Jacobsen SJ. Long-term school outcomes for children with attention-deficit/hyperactivity disorder: a population-based perspective. J. Dev. Behav. Pediatr.28(4), 265–273 (2007).
   PubMed Web of Science ®Google Scholar
• Biederman J, Petty CR, Monuteaux MC et al. Adult psychiatric outcomes of girls with attention deficit hyperactivity disorder: 11-year follow-up in a longitudinal case–control study. Am. J. Psychiatry167(4), 409–417 (2010).
   PubMed Web of Science ®Google Scholar
• Barkley R, Murphy KR, Fischer M. ADHD in Adults: What The Science Says. Guilford, New York, NY, USA (2007).
   Google Scholar
• Sobanski E, Banaschewski T, Asherson P et al. Emotional lability in children and adolescents with attention deficit hyperactivity disorder (ADHD): clinical correlates and familial prevalence. J. Child Psychol. Psychiatry51(8), 915–923 (2010).
   PubMed Web of Science ®Google Scholar
• Uekermann J, Kraemer M, Abdel-Hamid M et al. Social cognition in attention-deficit hyperactivity disorder (ADHD). Neurosci. Biobehav. Rev.34(5), 734–743 (2010).
   PubMed Web of Science ®Google Scholar
• Da Fonseca D, Seguier V, Santos AC, Poinso F, Deruelle C. Emotion understanding in children with ADHD. Child Psychiatry Hum. Dev.40(1), 111–121 (2009).
   PubMed Web of Science ®Google Scholar
• Hoza B, Gerdes AC, Mrug S et al. Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder. J. Clin. Child Adolesc. Psychol.34(1), 74–86 (2005).
   PubMed Web of Science ®Google Scholar
• Adler LA, Sutton VK, Moore RJ et al. Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine. J. Clin. Psychopharmacol.26(6), 648–652 (2006).
   PubMed Web of Science ®Google Scholar
• Klassen AF, Miller A, Fine S. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Pediatrics114(5), e541–e547 (2004).
   PubMed Web of Science ®Google Scholar
• Burt SA. Rethinking environmental contributions to child and adolescent psychopathology: a meta-analysis of shared environmental influences. Psychol. Bull.135(4), 608–637 (2009).
   PubMed Web of Science ®Google Scholar
• Faraone SV, Perlis RH, Doyle AE et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol. Psychiatry57(11), 1313–1323 (2005).
   PubMed Web of Science ®Google Scholar
• Epstein JN, Conners CK, Erhardt D et al. Familial aggregation of ADHD characteristics. J. Abnorm. Child Psychol.28(6), 585–594 (2000).
   PubMed Web of Science ®Google Scholar
• Sprich S, Biederman J, Crawford MH, Mundy E, Faraone SV. Adoptive and biological families of children and adolescents with ADHD. J. Am. Acad. Child Adolesc. Psychiatry39(11), 1432–1437 (2000).
   PubMed Web of Science ®Google Scholar
• Boomsma DI, Saviouk V, Hottenga JJ et al. Genetic epidemiology of attention deficit hyperactivity disorder (ADHD index) in adults. PLoS ONE5(5), e10621 (2010).
   PubMed Web of Science ®Google Scholar
• Schultz MR, Rabi K, Faraone SV, Kremen W, Lyons MJ. Efficacy of retrospective recall of attention-deficit hyperactivity disorder symptoms: a twin study. Twin Res. Hum. Genet.9(2), 220–232 (2006).
   PubMedGoogle Scholar
• van den Berg SM, Willemsen G, de Geus EJ, Boomsma DI. Genetic etiology of stability of attention problems in young adulthood. Am. J. Med. Genet. B Neuropsychiatr. Genet.141B(1), 55–60 (2006).
   PubMedGoogle Scholar
• McKinney J, Johansson S, Halmoy A et al. A loss-of-function mutation in tryptophan hydroxylase 2 segregating with attention-deficit/hyperactivity disorder. Mol. Psychiatry13(4), 365–367 (2008).
   PubMed Web of Science ®Google Scholar
• Walitza S, Renner TJ, Dempfle A et al. Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder. Mol. Psychiatry10(12), 1126–1132 (2005).
   PubMed Web of Science ®Google Scholar
• Cote F, Fligny C, Bayard E et al. Maternal serotonin is crucial for murine embryonic development. Proc. Natl Acad. Sci. USA104(1), 329–334 (2007).
   PubMed Web of Science ®Google Scholar
• Halmoy A, Johansson S, Winge I, McKinney JA, Knappskog PM, Haavik J. Attention-deficit/hyperactivity disorder symptoms in offspring of mothers with impaired serotonin production. Arch. Gen. Psychiatry67(10), 1033–1043 (2010).
   PubMed Web of Science ®Google Scholar
• Reif A, Jacob CP, Rujescu D et al. Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. Arch. Gen. Psychiatry66(1), 41–50 (2009).
   PubMed Web of Science ®Google Scholar
• Franke B, Neale BM, Faraone SV. Genome-wide association studies in ADHD. Hum. Genet.126(1), 13–50 (2009).
   PubMed Web of Science ®Google Scholar
• Arcos-Burgos M, Jain M, Acosta MT et al. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol. Psychiatry15(11), 1053–1066 (2010).
   PubMed Web of Science ®Google Scholar
• Ribases M, Ramos-Quiroga JA, Sanchez-Mora C et al. Contribution of LPHN3 to the genetic susceptibility to ADHD in adulthood: a replication study. Genes Brain Behav.10(2), 149–157 (2011).
   PubMed Web of Science ®Google Scholar
• Liu QR, Drgon T, Johnson C, Walther D, Hess J, Uhl GR. Addiction molecular genetics: 639,401 SNP whole genome association identifies many ‘cell adhesion’ genes. Am. J. Med. Genet. B Neuropsychiatr. Genet.141B(8), 918–925 (2006).
   PubMed Web of Science ®Google Scholar
• Davies G, Tenesa A, Payton A et al. Genome-wide association studies establish that human intelligence is highly heritable and polygenic. Mol. Psychiatry DOI: 10.1038/mp.2011.85 (2011) (Epub ahead of print).
   Google Scholar
• Langenhan T, Promel S, Mestek L et al. Latrophilin signaling links anterior-posterior tissue polarity and oriented cell divisions in the C. elegans embryo. Dev. Cell17(4), 494–504 (2009).
   PubMed Web of Science ®Google Scholar
• Jain M, Velez JI, Acosta MT et al. A cooperative interaction between LPHN3 and 11q doubles the risk for ADHD. Mol. Psychiatry DOI: 10.1038/mp.2011.59 (2011) (Epub ahead of print).
   PubMedGoogle Scholar
• Arcos-Burgos M, Castellanos FX, Pineda D et al. Attention-deficit/hyperactivity disorder in a population isolate: linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11. Am. J. Hum. Genet.75(6), 998–1014 (2004).
   PubMed Web of Science ®Google Scholar
• Faraone SV, Doyle AE, Lasky-Su J et al. Linkage analysis of attention deficit hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(8), 1387–1391 (2008).
   PubMedGoogle Scholar
• Ogdie MN, Fisher SE, Yang M et al. Attention deficit hyperactivity disorder: fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11. Am. J. Hum. Genet.75(4), 661–668 (2004).
   PubMedGoogle Scholar
• Romanos M, Freitag C, Jacob C et al. Genome-wide linkage analysis of ADHD using high-density SNP arrays: novel loci at 5q13.1 and 14q12. Mol. Psychiatry13(5), 522–530 (2008).
   PubMedGoogle Scholar
• Zhou K, Dempfle A, Arcos-Burgos M et al. Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(8), 1392–1398 (2008).
   PubMed Web of Science ®Google Scholar
• Lesch KP, Timmesfeld N, Renner TJ et al. Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J. Neural Trans.115(11), 1573–1585 (2008).
   PubMed Web of Science ®Google Scholar
• Reif A, Nguyen TT, Weisflog L et al. DIRAS2 is associated with adult ADHD, related traits, and co-morbid disorders. Neuropsychopharmacology DOI:10.1038/npp.2011.120 (2011) (Epub ahead of print).
   Google Scholar
• Neale BM, Medland SE, Ripke S et al. Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry49(9), 884–897 (2010).
   PubMed Web of Science ®Google Scholar
• Faraone SV, Doyle AE. The nature and heritability of attention-deficit/hyperactivity disorder. Child Adolesc. Psychiatr. Clin. N. Am.10(2), 299–316 (2001).
   PubMed Web of Science ®Google Scholar
• Manolio TA, Collins FS, Cox NJ et al. Finding the missing heritability of complex diseases. Nature461(7265), 747–753 (2009).
   PubMed Web of Science ®Google Scholar
• Bassett AS, Scherer SW, Brzustowicz LM. Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease. Am. J. Psychiatry167(8), 899–914 (2010).
   PubMed Web of Science ®Google Scholar
• Sebat J, Lakshmi B, Malhotra D et al. Strong association of de novo copy number mutations with autism. Science316(5823), 445–449 (2007).
   PubMed Web of Science ®Google Scholar
• Elia J, Gai X, Xie HM et al. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol. Psychiatry15(6), 637–646 (2010).
   PubMed Web of Science ®Google Scholar
• Lesch KP, Selch S, Renner TJ et al. Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree. Mol. Psychiatry16(5), 491–503 (2011).
   PubMed Web of Science ®Google Scholar
• Banerjee TD, Middleton F, Faraone SV. Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatr.96(9), 1269–1274 (2007).
   PubMed Web of Science ®Google Scholar
• van den Hove DLA, Jakob SB, Schraut KG et al. Sex-specific effects of prenatal stress in 5-HTT deficient mice: towards molecular mechanisms of gene x environment interactions. PLoS ONE6, e22715 (2011).
   PubMedGoogle Scholar
• Bradley WE, Raelson JV, Dubois DY et al. Hotspots of large rare deletions in the human genome. PLoS ONE5, e9401 (2010).
   PubMedGoogle Scholar
• Lesch KP. When the serotonin transporter gene meets adversity: the contribution of animal models to understanding epigenetic mechanisms in affective disorders and resilience. Curr. Top. Behav. Neurosci.7, 251–280 (2011).
   PubMedGoogle Scholar
• Williams NM, Zaharieva I, Martin A et al. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet376(9750), 1401–1408 (2010).
   PubMed Web of Science ®Google Scholar
• Valera EM, Faraone SV, Murray KE, Seidman LJ. Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol. Psychiatry61(12), 1361–1369 (2007).
   PubMed Web of Science ®Google Scholar
• Cao Q, Sun L, Gong G et al. The macrostructural and microstructural abnormalities of corpus callosum in children with attention deficit/hyperactivity disorder: a combined morphometric and diffusion tensor MRI study. Brain Res.1310, 172–180 (2010).
   PubMed Web of Science ®Google Scholar
• Hutchinson AD, Mathias JL, Banich MT. Corpus callosum morphology in children and adolescents with attention deficit hyperactivity disorder: a meta-analytic review. Neuropsychology22(3), 341–349 (2008).
   PubMed Web of Science ®Google Scholar
• Frodl T, Stauber J, Schaaff N et al. Amygdala reduction in patients with ADHD compared with major depression and healthy volunteers. Acta Psychiatr. Scand.121(2), 111–118 (2010).
   PubMedGoogle Scholar
• Seidman LJ, Valera EM, Makris N et al. Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/hyperactivity disorder identified by magnetic resonance imaging. Biol. Psychiatry60(10), 1071–1080 (2006).
   PubMed Web of Science ®Google Scholar
• Hesslinger B, Tebartz van Elst L, Thiel T, Haegele K, Hennig J, Ebert D. Frontoorbital volume reductions in adult patients with attention deficit hyperactivity disorder. Neurosci. Lett.328(3), 319–321 (2002).
   PubMed Web of Science ®Google Scholar
• Schneider M, Retz W, Coogan A, Thome J, Rösler M. Anatomical and functional brain imaging in adult attention-deficit/hyperactivity disorder (ADHD) – a neurological view. Eur. Arch. Psychiatry Clin. Neurosci.256(Suppl. 1), I32–I41 (2006).
   PubMed Web of Science ®Google Scholar
• Castellanos FX, Lee PP, Sharp W et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA288(14), 1740–1748 (2002).
   PubMed Web of Science ®Google Scholar
• Biederman J, Fried R, Petty CR et al. Cognitive development in adults with attention-deficit/hyperactivity disorder: a controlled study in medication-naive adults across the adult life cycle. J. Clin. Psychiatry72(1), 11–16 (2011).
   PubMedGoogle Scholar
• Martinussen R, Hayden J, Hogg-Johnson S, Tannock R. A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry44(4), 377–384 (2005).
   PubMed Web of Science ®Google Scholar
• Wåhlstedt C, Thorell L, Bohlin G. Heterogeneity in ADHD: neuropsychological pathways, comorbidity and symptom domains. J. Abnorm. Child Psychol.37(4), 551–564 (2009).
   PubMed Web of Science ®Google Scholar
• Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF. Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol. Psychiatry57(11), 1336–1346 (2005).
   PubMed Web of Science ®Google Scholar
• Bidwell LC, Willcutt EG, DeFries JC, Pennington BF. Testing for neuropsychological endophenotypes in siblings discordant for attention-deficit/hyperactivity disorder. Biol. Psychiatry62(9), 991–998 (2007).
   PubMed Web of Science ®Google Scholar
• Wolf RC, Plichta MM, Sambataro F et al. Regional brain activation changes and abnormal functional connectivity of the ventrolateral prefrontal cortex during working memory processing in adults with attention-deficit/hyperactivity disorder. Hum. Brain Mapp.30(7), 2252–2266 (2009).
   PubMed Web of Science ®Google Scholar
• Valera EM, Faraone SV, Biederman J, Poldrack RA, Seidman LJ. Functional neuroanatomy of working memory in adults with attention-deficit/hyperactivity disorder. Biol. Psychiatry57(5), 439–447 (2005).
   PubMed Web of Science ®Google Scholar
• Valera EM, Brown A, Biederman J et al. Sex differences in the functional neuroanatomy of working memory in adults with ADHD. Am. J. Psychiatry167(1), 86–94 (2010).
   PubMed Web of Science ®Google Scholar
• Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of brain function. Proc. Natl Acad. Sci. USA98(2), 676–682 (2001).
   PubMed Web of Science ®Google Scholar
• Singh KD, Fawcett IP. Transient and linearly graded deactivation of the human default-mode network by a visual detection task. NeuroImage41(1), 100–112 (2008).
   PubMedGoogle Scholar
• Li CS, Yan P, Bergquist KL, Sinha R. Greater activation of the ‘default’ brain regions predicts stop signal errors. NeuroImage38(3), 640–648 (2007).
   PubMed Web of Science ®Google Scholar
• Weissman DH, Roberts KC, Visscher KM, Woldorff MG. The neural bases of momentary lapses in attention. Nat. Neurosci.9(7), 971–978 (2006).
   PubMed Web of Science ®Google Scholar
• Castellanos FX, Margulies DS, Kelly C et al. Cingulate–precuneus interactions: a new locus of dysfunction in adult attention-deficit/hyperactivity disorder. Biol. Psychiatry63(3), 332–337 (2008).
   PubMed Web of Science ®Google Scholar
• Tian L, Jiang T, Liang M et al. Enhanced resting-state brain activities in ADHD patients: a fMRI study. Brain Dev.30(5), 342–348 (2008).
   PubMed Web of Science ®Google Scholar
• Peterson BS, Potenza MN, Wang Z et al. An fMRI study of the effects of psychostimulants on default-mode processing during Stroop task performance in youths with ADHD. Am. J. Psychiatry166(11), 1286–1294 (2009).
   PubMed Web of Science ®Google Scholar
• Sonuga-Barke EJ, Castellanos FX. Spontaneous attentional fluctuations in impaired states and pathological conditions: a neurobiological hypothesis. Neurosci. Biobehav. Rev.31(7), 977–986 (2007).
   PubMed Web of Science ®Google Scholar
• Konrad K, Eickhoff SB. Is the ADHD brain wired differently? A review on structural and functional connectivity in attention deficit hyperactivity disorder. Hum. Brain Mapp.31(6), 904–916 (2010).
   PubMed Web of Science ®Google Scholar
• Faraone SV. Using meta-analysis to compare the efficacy of medications for attention-deficit/hyperactivity disorder in youths. PT34(12), 678–694 (2009).
   PubMedGoogle Scholar
• Faraone SV, Buitelaar J. Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. Eur. Child Adolesc. Psychiatry19(4), 353–364 (2010).
   PubMed Web of Science ®Google Scholar
• Newcorn JH, Sutton VK, Weiss MD, Sumner CR. Clinical responses to atomoxetine in attention-deficit/hyperactivity disorder: the integrated data exploratory analysis (IDEA) study. J. Am. Acad. Child Adolesc. Psychiatry48(5), 511–518 (2009).
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Clin. Ther.28(2), 266–279 (2006).
   PubMed Web of Science ®Google Scholar
• McGough JJ, Biederman J, Wigal SB et al. Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD. J. Am. Acad. Child Adolesc. Psychiatry44(6), 530–538 (2005).
   PubMed Web of Science ®Google Scholar
• Biederman J, Lopez FA, Boellner SW, Chandler MC. A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder. Pediatrics110(I2), 258–266 (2002).
   PubMed Web of Science ®Google Scholar
• McCracken JT, Biederman J, Greenhill LL et al. Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD. J. Am. Acad. Child Adolesc. Psychiatry42(6), 673–683 (2003).
   PubMed Web of Science ®Google Scholar
• Wigal SB. Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults. CNS Drugs23(Suppl. 1), 21–31 (2009).
   PubMed Web of Science ®Google Scholar
• Gustafsson P, Hansson K, Eidevall L, Thernlund G, Svedin CG. Treatment of ADHD with amphetamine: short-term effects on family interaction. J. Atten. Disord.12(1), 83–91 (2008).
   PubMedGoogle Scholar
• Faraone SV, Glatt SJ. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J. Clin. Psychiatry71(6), 754–763 (2010).
   PubMed Web of Science ®Google Scholar
• Castells X, Ramos-Quiroga JA, Rigau D et al. Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis. CNS Drugs25(2), 157–169 (2011).
   PubMed Web of Science ®Google Scholar
• Biederman J, Mick E, Surman C et al. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol. Psychiatry59(9), 829–835 (2006).
   PubMed Web of Science ®Google Scholar
• Koesters M, Becker T, Kilian R, Fegert JM, Weinmann S. Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder. J. Psychopharmacol.23(7), 733–744 (2009).
   PubMed Web of Science ®Google Scholar
• Rösler M, Fischer R, Ammer R, Ose C, Retz W. A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. Eur. Arch. Psychiatry Clin. Neurosci.259(2), 120–129 (2009).
   PubMed Web of Science ®Google Scholar
• Wender PH, Reimherr FW, Marchant BK, Sanford ME, Czajkowski LA, Tomb DA. A one year trial of methylphenidate in the treatment of ADHD. J. Atten. Disord.15(1), 36–45 (2011).
   PubMed Web of Science ®Google Scholar
• Edel MA, Pfutze EM, Lieder A et al. Self concept, action control and ADHD symptoms under methylphenidate treatment in adults with ADHD. Pharmacopsychiatry42(3), 109–113 (2009).
   PubMed Web of Science ®Google Scholar
• Adler LA, Goodman DW, Kollins SH et al. Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J. Clin. Psychiatry69(9), 1364–1373 (2008).
   PubMed Web of Science ®Google Scholar
• Castells X, Ramos-Quiroga JA, Bosch R, Nogueira M, Casas M. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst. Rev.6, CD007813 (2011).
   PubMedGoogle Scholar
• Weisler R, Young J, Mattingly G et al. Long-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. CNS Spectr.14(10), 573–585 (2009).
   PubMed Web of Science ®Google Scholar
• Wigal T, Brams M, Gasior M, Gao J, Squires L, Giblin J. Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design. Behav. Brain Funct.6, 34 (2010).
   PubMed Web of Science ®Google Scholar
• Pliszka SR, Matthews TL, Braslow KJ, Watson MA. Comparative effects of methylphenidate and mixed salts amphetamine on height and weight in children with attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry45(5), 520–526 (2006).
   PubMedGoogle Scholar
• Mészáros Á, Czobor P, Bálint S, Komlósi S, Simon V, Bitter I. Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis. Intl J. Neuropsychopharmacol.12(8), 1137–1147 (2009).
   PubMed Web of Science ®Google Scholar
• Biederman J, Pliszka SR. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents. J. Pediatr.152(3), 394–399 (2008).
   PubMed Web of Science ®Google Scholar
• Taylor FB, Russo J. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. J. Child Adolesc. Psychopharmacol.10(4), 311–320 (2000).
   PubMed Web of Science ®Google Scholar
• Biederman J, Melmed RD, Patel A, McBurnett K, Donahue J, Lyne A. Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD. CNS Spectr.13(12), 1047–1055 (2008).
   PubMed Web of Science ®Google Scholar
• Biederman J, Melmed RD, Patel A et al. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics121(1), e73–e84 (2008).
   PubMed Web of Science ®Google Scholar
• Connor DF, Findling RL, Kollins SH et al. Effects of guanfacine extended release on oppositional symptoms in children aged 6–12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial. CNS Drugs24(9), 755–768 (2010).
   PubMed Web of Science ®Google Scholar
• Sallee FR, Lyne A, Wigal T, McGough JJ. Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. J. Child Adolesc. Psychopharmacol.19(3), 215–226 (2009).
   PubMed Web of Science ®Google Scholar
• Sallee FR, McGough J, Wigal T, Donahue J, Lyne A, Biederman J. Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial. J. Am. Acad. Child Adolesc. Psychiatry48(2), 155–165 (2009).
   PubMed Web of Science ®Google Scholar
• Conners CK, Casat CD, Gualtieri CT et al. Bupropion hydrochloride in attention deficit disorder with hyperactivity. J. Am. Acad. Child Adolesc. Psychiatry35(10), 1314–1321 (1996).
   PubMed Web of Science ®Google Scholar
• Reimherr FW, Hedges DW, Strong RE, Marchant BK, Williams ED. Bupropion SR in adults with ADHD: a shortterm, placebo-controlled trial. Neuropsychiatr. Dis. Treat.1(3), 245–251 (2005).
   PubMedGoogle Scholar
• Adler LA, Spencer T, Brown TE et al. Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial. J. Clin. Psychopharmacol.29(1), 44–50 (2009).
   PubMed Web of Science ®Google Scholar
• Brown TE, Holdnack J, Saylor K et al. Effect of atomoxetine on executive function impairments in adults with ADHD. J. Atten. Disord.15(2), 130–138 (2011).
   PubMed Web of Science ®Google Scholar
• Adler LA, Spencer TJ, Williams DW, Moore RJ, Michelson D. Long-term, open-label safety and efficacy of atomoxetine in adults with ADHD: final report of a 4-year study. J. Atten. Disord.12(3), 248–253 (2008).
   PubMed Web of Science ®Google Scholar
• Martenyi F, Zavadenko NN, Jarkova NB et al. Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia. Eur. Child Adolesc. Psychiatry19(1), 57–66 (2010).
   PubMed Web of Science ®Google Scholar
• Surman C, Hammerness P, Petty C et al. Atomoxetine in the treatment of adults with subthreshold and/or late onset attention-deficit hyperactivity disorder-not otherwise specified (ADHD-NOS): a prospective open-label 6-week study. CNS Neurosci. Ther.16(1), 6–12 (2010).
   PubMed Web of Science ®Google Scholar
• Young S, Amarasinghe JM. Practitioner review: non-pharmacological treatments for ADHD: a lifespan approach. J. Child Psychol. Psychiatry51(2), 116–133 (2010).
   PubMed Web of Science ®Google Scholar
• NICE. The NICE Guideline on Diagnosis and Managment of ADHD in Children, Young People and Adults. The British Psychological Society and The Royal College of Psychiatrists, London, UK (2008).
   Google Scholar
• Pelham WE, Fabiano GA. Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder. J. Clin. Child Adolesc. Psychol.37(1), 184–214 (2008).
   PubMed Web of Science ®Google Scholar
• Chronis AM, Chacko A, Fabiano GA, Wymbs BT, Pelham WE Jr. Enhancements to the behavioral parent training paradigm for families of children with ADHD: review and future directions. Clin. Child Fam. Psychol. Rev.7(1), 1–27 (2004).
   PubMed Web of Science ®Google Scholar
• Pelham WE, Gnagy EM, Greiner AR et al. Behavioral versus behavioral and pharmacological treatment in ADHD children attending a summer treatment program. J. Abnorm. Child Psychol.28(6), 507–525 (2000).
   PubMed Web of Science ®Google Scholar
• The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry56(12), 1073–1086 (1999).
   PubMed Web of Science ®Google Scholar
• Conners CK, Epstein JN, March JS et al. Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. J. Am. Acad. Child Adolesc. Psychiatry40(2), 159–167 (2001).
   PubMed Web of Science ®Google Scholar
• Hinshaw SP, Owens EB, Wells KC et al. Family processes and treatment outcome in the MTA: negative/ineffective parenting practices in relation to multimodal treatment. J. Abnorm. Child Psychol.28(6), 555–568 (2000).
   PubMed Web of Science ®Google Scholar
• Jensen PS, Arnold LE, Swanson JM et al. 3-year follow-up of the NIMH MTA study. J. Am. Acad. Child Adolesc. Psychiatry46(8), 989–1002 (2007).
   PubMed Web of Science ®Google Scholar
• Molina BSG, Hinshaw SP, Swanson JM et al. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J. Am. Acad. Child Adolesc. Psychiatry48(5), 484–500 (2009).
   PubMed Web of Science ®Google Scholar
• Owens EB, Hinshaw SP, Kraemer HC et al. Which treatment for whom for ADHD? Moderators of treatment response in the MTA. J. Consult. Clin. Psychol.71(3), 540–552 (2003).
   PubMed Web of Science ®Google Scholar
• Swanson JM, Kraemer HC, Hinshaw SP et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J. Am. Acad. Child Adolesc. Psychiatry40(2), 168–179 (2001).
   PubMed Web of Science ®Google Scholar
• Wells KC, Pelham WE, Kotkin RA et al. Psychosocial treatment strategies in the MTA study: rationale, methods, and critical issues in design and implementation. J. Abnorm. Child Psychol.28(6), 483–505 (2000).
   PubMed Web of Science ®Google Scholar
• The MTA Cooperative Group. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the multimodal treatment study of children with attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry56(12), 1088–1096 (1999).
   PubMed Web of Science ®Google Scholar
• Safren SA, Sprich S, Mimiaga MJ et al. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. JAMA304(8), 875–880 (2010).
   PubMed Web of Science ®Google Scholar
• Safren SA, Otto MW, Sprich S, Winett CL, Wilens TE, Biederman J. Cognitive–behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav. Res. Ther.43(7), 831–842 (2005).
   PubMed Web of Science ®Google Scholar
• Bramham J, Young S, Bickerdike A, Spain D, McCartan D, Xenitidis K. Evaluation of group cognitive behavioral therapy for adults with ADHD. J. Atten. Disord.12(5), 434–441 (2009).
   PubMed Web of Science ®Google Scholar
• Solanto MV, Marks DJ, Wasserstein J et al. Efficacy of meta-cognitive therapy for adult ADHD. Am. J. Psychiatry167(8), 958–968 (2010).
   PubMed Web of Science ®Google Scholar
• Kuntsi J, Rijsdijk F, Ronald A, Asherson P, Plomin R. Genetic influences on the stability of attention-deficit/hyperactivity disorder symptoms from early to middle childhood. Biol. Psychiatry57(6), 647–654 (2005).
   PubMed Web of Science ®Google Scholar
• Larsson JO, Larsson H, Lichtenstein P. Genetic and environmental contributions to stability and change of ADHD symptoms between 8 and 13 years of age: a longitudinal twin study. J. Am. Acad. Child Adolesc. Psychiatry43(10), 1267–1275 (2004).
   PubMed Web of Science ®Google Scholar
• Baker KL, Rees MI, Thompson PW et al. Chromosome 2 interstitial deletion (del(2)(q14.1q21)) associated with connective tissue laxity and an attention deficit disorder. J. Med. Genet.38(7), 493–496 (2001).
   PubMedGoogle Scholar
• Cappellacci S, Martinelli S, Rinaldi R et al.De novo pure 12q22q24.33 duplication: first report of a case with mental retardation, ADHD, and Dandy-Walker malformation. Am. J. Med. Genet. A140(11), 1203–1207 (2006).
   PubMedGoogle Scholar
• Mazei-Robison MS, Couch RS, Shelton RC, Stein MA, Blakely RD. Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder. Neuropharmacology49(6), 724–736 (2005).
   PubMed Web of Science ®Google Scholar
• Lo-Castro A, D’Agati E, Curatolo P. ADHD and genetic syndromes. Brain Dev.33(6), 456–461 (2011).
   PubMedGoogle Scholar
• Hawi Z, Segurado R, Conroy J et al. Preferential transmission of paternal alleles at risk genes in attention-deficit/hyperactivity disorder. Am. J. Hum. Genet.77(6), 958–965 (2005).
   PubMedGoogle Scholar
• Doyle AE, Willcutt EG, Seidman LJ et al. Attention-deficit/hyperactivity disorder endophenotypes. Biol. Psychiatry57(11), 1324–1335 (2005).
   PubMed Web of Science ®Google Scholar
• Nigg JT, Blaskey LG, Stawicki JA, Sachek J. Evaluating the endophenotype model of ADHD neuropsychological deficit: results for parents and siblings of children with ADHD combined and inattentive subtypes. J. Abnorm. Psychol.113(4), 614–625 (2004).
   PubMed Web of Science ®Google Scholar
• Shaw P, Lerch J, Greenstein D et al. Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry63(5), 540–549 (2006).
   PubMed Web of Science ®Google Scholar
• Shaw P, Eckstrand K, Sharp W et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. PNAS104(49), 19649–19654 (2007).
   PubMed Web of Science ®Google Scholar
• Shaw P, Sharp WS, Morrison M et al. Psychostimulant treatment and the developing cortex in attention deficit hyperactivity disorder. Am. J. Psychiatry166(1), 58–63 (2009).
   PubMed Web of Science ®Google Scholar
• Makris N, Biederman J, Valera EM et al. Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder. Cerebral Cortex17(6), 1364–1375 (2007).
   PubMed Web of Science ®Google Scholar
• Wolosin SM, Richardson ME, Hennessey JG, Denckla MB, Mostofsky SH. Abnormal cerebral cortex structure in children with ADHD. Hum. Brain Mapp.30(1), 175–184 (2009).
   PubMed Web of Science ®Google Scholar
• Shaw P, Lalonde F, Lepage C et al. Development of cortical asymmetry in typically developing children and its disruption in attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry66(8), 888–896 (2009).
   PubMed Web of Science ®Google Scholar
• Hamilton LS, Levitt JG, O’Neill J et al. Reduced white matter integrity in attention-deficit hyperactivity disorder. Neuroreport19(17), 1705–1708 (2008).
   PubMed Web of Science ®Google Scholar
• Ashtari M, Kumra S, Bhaskar SL et al. Attention-deficit/hyperactivity disorder: a preliminary diffusion tensor imaging study. Biol. Psychiatry57(5), 448–455 (2005).
   PubMed Web of Science ®Google Scholar
• Green C. Methylphenidate vs dexamphetamine: a clinical audit. J. Paediatr. Child Health32(5), 470 (1996).
   PubMedGoogle Scholar
• Arnold LE. Methyiphenidate vs. amphetamine: comparative review. J. Atten. Disord.3(4), 200–211 (2000).
   Google Scholar
• Montoya A, Colom F, Ferrin M. Is psychoeducation for parents and teachers of children and adolescents with ADHD efficacious? A systematic literature review. Eur. Psychiatry26(3), 166–175 (2011).
   PubMed Web of Science ®Google Scholar
• Kooij SJJ, Bejerot S, Blackwell A et al. European consensus statement on diagnosis and treatment of adult ADHD: the European Network Adult ADHD. BMC Psychiatry10, 67 (2010).
   PubMed Web of Science ®Google Scholar
• Halperin JM, Schulz KP. Revisiting the role of the prefrontal cortex in the pathophysiology of attention-deficit/hyperactivity disorder. Psychol. Bull.132(4), 560–581 (2006).
   PubMed Web of Science ®Google Scholar
• Halperin JM, Trampush JW, Miller CJ, Marks DJ, Newcorn JH. Neuropsychological outcome in adolescents/young adults with childhood ADHD: profiles of persisters, remitters and controls. J. Child Psychol. Psychiatry49(9), 958–966 (2008).
   PubMed Web of Science ®Google Scholar
• Sagvolden T. The attention deficit disorder might be a reinforcement deficit disorder. In: Contemporary Psychology in Europe: Theory, Research and Application. Georgas J, Manthouli M, Besevegis E, Kokkevi A (Eds). Hogrefe and Huber, Gottengin, Germany, 131–143 (1991).
   Google Scholar
• Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol. Bull.121(1), 65–94 (1997).
   PubMed Web of Science ®Google Scholar
• Nigg JT. Is ADHD a disinhibitory disorder? Psychol. Bull.127(5), 571–598 (2001).
   PubMed Web of Science ®Google Scholar
• Sergeant J. The cognitive–energetic model: an empirical approach to attention-deficit hyperactivity disorder. Neurosci. Biobehav. Rev.24(1), 7–12 (2000).
   PubMed Web of Science ®Google Scholar
• Sagvolden T, Johansen EB, Aase H, Russell VA. A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav. Brain Sci.28(3), 397–419 (2005).
   PubMed Web of Science ®Google Scholar
• Lesch KP. Alcohol dependence and gene x environment interaction in emotion regulation: is serotonin the link? Eur. J. Pharmacol.526, 113–124 (2005).
   PubMedGoogle Scholar